Compare PLTK & INVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PLTK | INVA |
|---|---|---|
| Founded | 2010 | 1996 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 1.5B |
| IPO Year | 2021 | 2004 |
| Metric | PLTK | INVA |
|---|---|---|
| Price | $3.51 | $19.41 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 9 | 5 |
| Target Price | $6.61 | ★ $36.80 |
| AVG Volume (30 Days) | ★ 1.0M | 855.5K |
| Earning Date | 02-26-2026 | 02-25-2026 |
| Dividend Yield | ★ 11.40% | N/A |
| EPS Growth | N/A | ★ 53.96 |
| EPS | 0.23 | ★ 1.52 |
| Revenue | ★ $2,726,900,000.00 | $388,521,000.00 |
| Revenue This Year | $9.52 | $13.23 |
| Revenue Next Year | $2.58 | $8.58 |
| P/E Ratio | $15.19 | ★ $12.75 |
| Revenue Growth | 7.49 | ★ 10.14 |
| 52 Week Low | $3.31 | $16.52 |
| 52 Week High | $7.58 | $22.76 |
| Indicator | PLTK | INVA |
|---|---|---|
| Relative Strength Index (RSI) | 31.86 | 40.65 |
| Support Level | $3.53 | $19.00 |
| Resistance Level | $3.72 | $19.84 |
| Average True Range (ATR) | 0.13 | 0.49 |
| MACD | -0.04 | 0.00 |
| Stochastic Oscillator | 5.03 | 32.52 |
Playtika Holding Corp is engaged in developing mobile games. Some of its games include Board Kings, House of Fun, Poker Heat, Slotomania, and Bingo Blitz. The company has built live game operations services and a proprietary technology platform to support its portfolio of games. It derives revenue from the sale of virtual items associated with online games. Geographically, the group has a business presence in the USA, EMEA, APAC, and Other regions of which key revenue is derived from the USA. It offers both Mobile and Web-based platforms.
Innoviva Inc is a company with a portfolio of royalties healthcare assets. It has three primary sets of assets: a royalty portfolio, operating assets in critical care and infectious disease, and other strategic healthcare assets. Its product offering includes Relvar/Breo/Ellipta, Anoro, Ellipta, Trelegy, Ellipta and others.